Cerity Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Buy |
12,843
+5,600
| +77% | +$1.61M | 0.01% | 948 |
|
|
2025
Q1 | $2.23M | Sell |
7,243
-4,345
| -37% | -$1.34M | ﹤0.01% | 1064 |
|
|
2024
Q4 | $4.1M | Buy |
11,588
+2,702
| +30% | +$956K | 0.01% | 794 |
|
|
2024
Q3 | $3.18M | Buy |
8,886
+4,005
| +82% | +$1.44M | 0.01% | 885 |
|
|
2024
Q2 | $1.55M | Sell |
4,881
-700
| -13% | -$223K | ﹤0.01% | 1026 |
|
|
2024
Q1 | $1.28M | Buy |
5,581
+3,672
| +192% | +$844K | ﹤0.01% | 1162 |
|
|
2023
Q4 | $420K | Buy |
+1,909
| New | +$420K | ﹤0.01% | 1339 |
|
|
2023
Q3 | – | Sell |
-1,957
| Closed | -$432K | – | 1707 |
|
|
2023
Q2 | $432K | Buy |
1,957
+83
| +4% | +$18.3K | ﹤0.01% | 1245 |
|
|
2023
Q1 | $420K | Sell |
1,874
-70
| -4% | -$15.7K | ﹤0.01% | 1374 |
|
|
2022
Q4 | $541K | Buy |
+1,944
| New | +$541K | ﹤0.01% | 911 |
|
|
2020
Q1 | – | Sell |
-3,669
| Closed | -$323K | – | 522 |
|
|
2019
Q4 | $323K | Buy |
3,669
+765
| +26% | +$67.3K | 0.02% | 420 |
|
|
2019
Q3 | $232K | Buy |
2,904
+8
| +0.3% | +$639 | 0.01% | 432 |
|
|
2019
Q2 | $226K | Buy |
2,896
+119
| +4% | +$9.29K | 0.01% | 436 |
|
|
2019
Q1 | $326K | Buy |
2,777
+34
| +1% | +$3.99K | 0.02% | 406 |
|
|
2018
Q4 | $299K | Buy |
2,743
+750
| +38% | +$81.8K | 0.02% | 406 |
|
|
2018
Q3 | $255K | Sell |
1,993
-194
| -9% | -$24.8K | 0.02% | 456 |
|
|
2018
Q2 | $247K | Sell |
2,187
-113
| -5% | -$12.8K | 0.02% | 469 |
|
|
2018
Q1 | $258K | Buy |
2,300
+314
| +16% | +$35.2K | 0.02% | 466 |
|
|
2017
Q4 | $294K | Buy |
1,986
+4
| +0.2% | +$592 | 0.02% | 453 |
|
|
2017
Q3 | $232K | Buy |
1,982
+1
| +0.1% | +$117 | 0.02% | 501 |
|
|
2017
Q2 | $257K | Buy |
1,981
+15
| +0.8% | +$1.95K | 0.02% | 307 |
|
|
2017
Q1 | $266K | Buy |
+1,966
| New | +$266K | 0.02% | 365 |
|